SEP-380135

DRUG2 trials

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc.

Conditions

Bipolar DisorderMajor Depressive Disorder (MDD)Schizophrenia

Phase 1

A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

CompletedNCT07305779

Otsuka Pharmaceutical Development & Commercialization, Inc.Schizophrenia

Start: 2025-03-07End: 2025-05-03Updated: 2026-01-15

A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

CompletedNCT07549581

Otsuka Pharmaceutical Development & Commercialization, Inc.Bipolar Disorder, Major Depressive Disorder (MDD), Schizophrenia

Start: 2024-11-07End: 2025-09-12Updated: 2026-04-24